OCLASSEN PHARMA INC has a total of 35 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Australia and India. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are BOEHRINGER MANNHEIM PHARM CORP, DYNOGEN PHARMACEUTICALS INC and ALNAPHARM GMBH & CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | India | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | African Regional Industrial Property Organization | 1 | |
#6 | Belgium | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Colombia | 1 | |
#11 | Estonia | 1 | |
#12 | EPO (European Patent Office) | 1 | |
#13 | Spain | 1 | |
#14 | France | 1 | |
#15 | Greece | 1 | |
#16 | Israel | 1 | |
#17 | Italy | 1 | |
#18 | Lithuania | 1 | |
#19 | Latvia | 1 | |
#20 | Mexico | 1 | |
#21 | Norway | 1 | |
#22 | New Zealand | 1 | |
#23 | African Intellectual Property Organization | 1 | |
#24 | Philippines | 1 | |
#25 | Portugal | 1 | |
#26 | Slovenia | 1 | |
#27 | Taiwan | 1 | |
#28 | Yugoslavia (Serbia and Montenegro) | 1 | |
#29 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Heterocyclic compounds | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Adair Dennis W | 31 |
#2 | Smiles Kenneth A | 24 |
#3 | King Dannie | 21 |
#4 | Johnson Karl M | 3 |
#5 | Kern Earl R | 3 |
#6 | Dannie King | 2 |
#7 | King Dannie H | 2 |
#8 | King Danie H | 1 |
#9 | Smiles Kennethh A | 1 |
#10 | Jennings Rex A | 1 |
Publication | Filing date | Title |
---|---|---|
US6040298A | Methods for treatment with compositions effective against acyclovir-resistant strains of herpes viruses | |
US5432165A | Methods for the treatment of infection caused by Hepatitis B virus (HBV) | |
TW217986B | Compositions for the treatment of infection and disease caused by HBV | |
US5116328A | Diagnostic kit for the detection of atypical epithelia | |
US5057616A | Podophyllotoxin purification process |